Bodycote (LON:BOY) has been assigned an average rating of “Buy” from the fourteen analysts that are currently covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, four have issued a hold rating and nine have issued a buy rating on the company. The average 1-year price objective among analysts that have covered the stock in the last year is GBX 989.09 ($13.79).
A number of analysts have issued reports on the company. Barclays reaffirmed an “overweight” rating on shares of Bodycote in a research note on Tuesday, January 16th. JPMorgan Chase reissued a “neutral” rating and set a GBX 850 ($11.85) target price on shares of Bodycote in a research note on Tuesday, January 16th. Liberum Capital reissued a “buy” rating and set a GBX 1,050 ($14.64) target price on shares of Bodycote in a research note on Wednesday, January 24th. Peel Hunt raised their target price on Bodycote from GBX 965 ($13.46) to GBX 1,000 ($13.95) and gave the stock a “buy” rating in a research note on Tuesday, March 13th. Finally, Numis Securities reissued a “hold” rating and set a GBX 925 ($12.90) target price on shares of Bodycote in a research note on Friday, March 9th.
In other news, insider Stephen C. Harris sold 25,054 shares of Bodycote stock in a transaction on Monday, April 23rd. The stock was sold at an average price of GBX 915 ($12.76), for a total value of £229,244.10 ($319,726.78). Also, insider Anne Quinn acquired 9,000 shares of the company’s stock in a transaction dated Tuesday, March 6th. The stock was purchased at an average cost of GBX 932 ($13.00) per share, with a total value of £83,880 ($116,987.45).
BOY traded up GBX 1.50 ($0.02) on Thursday, hitting GBX 890 ($12.41). 176,053 shares of the company’s stock traded hands, compared to its average volume of 483,340. The company has a market capitalization of $1,780.00 and a PE ratio of 1,864.58. Bodycote has a one year low of GBX 728.50 ($10.16) and a one year high of GBX 1,043 ($14.55).
Bodycote (LON:BOY) last issued its earnings results on Tuesday, March 6th. The company reported GBX 49.20 ($0.69) earnings per share (EPS) for the quarter, beating the consensus estimate of GBX 47.20 ($0.66) by GBX 2 ($0.03). The company had revenue of £690.20 million for the quarter. Bodycote had a return on equity of 13.56% and a net margin of 12.61%.
The company also recently disclosed a dividend, which will be paid on Friday, June 1st. Stockholders of record on Thursday, April 19th will be paid a GBX 37.10 ($0.52) dividend. The ex-dividend date of this dividend is Thursday, April 19th. This is a boost from Bodycote’s previous dividend of $5.30. This represents a dividend yield of 3.96%.
WARNING: This piece was originally posted by The Lincolnian Online and is owned by of The Lincolnian Online. If you are accessing this piece on another site, it was stolen and republished in violation of international copyright & trademark laws. The legal version of this piece can be viewed at https://www.thelincolnianonline.com/2018/05/18/bodycote-boy-receives-consensus-recommendation-of-buy-from-analysts.html.
Bodycote Company Profile
Bodycote plc provides thermal processing services worldwide. The company operates in two business areas, Aerospace, Defence & Energy; and Automotive & General Industrial. It offers heat treatment services, including altering the microstructure of metals and alloys, such as steel and aluminum to impart properties comprising surface hardness, temperature resistance, ductility, and strength; metal joining services consisting of electron beam welding, and vacuum and honeycomb brazing; and Hot isostatic pressing (HIP) services, including HIP product fabrication, isostatic pressing, and HIP supporting services.
Receive News & Ratings for Bodycote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bodycote and related companies with MarketBeat.com's FREE daily email newsletter.